Скачать или смотреть Novel drug slows down glioma progression

#braincancer #cancermedication #gliomas

In an international study co-led by UCLA, scientists have shown that a new targeted therapy drug can extend the amount of time people with a subtype of glioma are on treatment without their cancer worsening. The finding suggests a possible new treatment option for people with
the slow-growing but deadly brain tumor.
The team found the drug vorasidenib more than doubled progression-free survival in people with recurrent grade glioma with IDH1 and IDH2 mutations. Compared with people who received a placebo, those who took vorasidenib went for nearly 17 more months without their
cancer worsening, delaying the time before they needed to begin chemotherapy and radiation.

Get the latest medical and health news at medicaldialogues.in
Follow us on
Twitter:   / medicaldialogs  
Facebook:   / medicaldialogues  
Instagram:   / medicaldialogues  
LinkedIn:   / medical-dialogues  
Website: https://medicaldialogues.in/